Jiwanram Sheoduttrai IPO vs Saroja Pharma IPO

Comparison between Jiwanram Sheoduttrai IPO and Saroja Pharma IPO.

IPO Details

Jiwanram Sheoduttrai IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Jiwanram Sheoduttrai IPO is up to ₹16.22 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Jiwanram Sheoduttrai IPO is ₹23.00 per share and of Saroja Pharma IPO is ₹84.00 per share.

 Jiwanram Sheoduttrai IPOSaroja Pharma IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹23.00 per share₹84.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size6000 shares1600 shares
Fresh Issue Size70,50,000 shares10,30,400 shares
Fresh Issue Size (Amount)up to ₹16.22 Crup to ₹8.66 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total70,50,000 shares10,30,400 shares
Issue Size Total (Amount)up to ₹16.22 Crup to ₹8.66 Cr

IPO Timetable

Jiwanram Sheoduttrai IPO opens on Sep 08, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Jiwanram Sheoduttrai IPO and Saroja Pharma IPO is Sep 12, 2023, and Sep 05, 2023, respectively.

 Jiwanram Sheoduttrai IPOSaroja Pharma IPO
Issue OpenSep 08, 2023Aug 31, 2023
Issue CloseSep 12, 2023Sep 05, 2023
Basis Of Allotment (Tentative)Sep 15, 2023Sep 08, 2023
Initiation of Refunds (Tentative)Sep 18, 2023Sep 11, 2023
Credit of Share (Tentative)Sep 20, 2023Sep 12, 2023
Listing date (Tentative)Sep 18, 2023Sep 13, 2023

Financials & KPIs

Jiwanram Sheoduttrai IPO P/E ratio is 9.91, as compared to Saroja Pharma IPO P/E ratio of 23.25.

 Jiwanram Sheoduttrai IPOSaroja Pharma IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets121.12113.77121.04
Total Income45.9834.1532.81
Profit After Tax4.031.500.03
NET Worth48.0244.2843.07
Reserves and Surplus30.7039.3338.12
Total Borrowing52.5952.3148.84
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets21.3415.518.22
Total Income50.3555.9636.75
Profit After Tax1.061.140.73
NET Worth5.094.030.94
Reserves and Surplus2.153.800.93
Total Borrowing10.196.143.02
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)70.01%73.02%
P/E Ratio9.9123.25
Market Cap₹56.92 Cr.₹33.77 Cr.
ROE8.3815
ROCE7.2925
Debt/Equity1.102.00
EPS₹2.32₹3.61
RoNW8.3820.85

Shares Offered

In the Jiwanram Sheoduttrai IPO Retail Individual Investors (RII) are offered 35,28,000 shares while in Saroja Pharma IPO retail investors are offered 35,28,000 shares. Qualified Institutional Buyers (QIB) are offered in Jiwanram Sheoduttrai IPO and in Saroja Pharma IPO.

 Jiwanram Sheoduttrai IPOSaroja Pharma IPO
Market Maker Reservation3,72,000 shares54,400 shares
NII35,22,000 shares5,15,200 shares
RII35,28,000 shares5,15,200 shares
Total70,50,000 shares10,30,400 shares

Bids Received (Subscription)

Jiwanram Sheoduttrai IPO subscribed 110.65x in total, whereas Saroja Pharma IPO subscribed 8.86x.

 Jiwanram Sheoduttrai IPOSaroja Pharma IPO
NII (times)69.75x2.90x
RII (times)151.47x14.83x
Total (times)110.65x8.86x

Compare with others

Compare:

Jiwanram Sheoduttrai IPO Vs Saroja Pharma IPO